Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Sell Canopy Growth Stock Right Now, and Buy It Back Cheaper in August

By Chris Lau, InvestorPlace Contributor

Canopy Growth bled money again in the last quarter as Multi-State Operators posted profits, suggesting the latter is a better investment.

Here’s the Reason the Prospects for Nio Stock Just Keep Looking Better

By Chris Lau, InvestorPlace Contributor

Nio deliveries continued to grow last month and are poised to rise, as consumer interest in electric vehicle gains in momentum.

Sell Sundial Stock First Before Everyone Else

By Chris Lau, InvestorPlace Contributor

SNDL stock peaked last week, giving suffering shareholders one chance to exit a company that loses money quarterly

Beware of a Massive Sell-Off in FCEL Stock

By Chris Lau, InvestorPlace Contributor

FuelCell Energy enjoyed a tremendous run-up that began just months ago but look out for the drop in trading volume

7 Stocks That Could Crash if They Show Weakness

By Chris Lau, InvestorPlace Contributor

Markets enjoyed an uptrend for a year, so with investors making easy money everywhere, the risks of stocks that could crash are on the rise.

Load More